Jihad Aljabban

Dr. Jihad Aljabban


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
LHLaith K. Hasan
Laith K. Hasan
JAJihad Aljabban
Jihad Aljabban
MRMichael Rohr
Michael Rohr
MMMohamed Mukhtar
Mohamed Mukhtar
NANikhil Adapa
Nikhil Adapa
WJWael Jarjour
Wael Jarjour
Objective.: Osteoporosis is a growing healthcare burden. By identifying osteoporosis-promoting genetic variations, we can spotlight targets for new pharmacologic therapies that will improve patient outcomes. In this metaanalysis, we analyzed mesenchymal stem cell (MSC) biomarkers in patients with osteoporosis.Methods.: We employed our Search Tag Analyze Resource for the Gene Expression Omnibus (STARGEO) platform to conduct a metaanalysis to define osteoporosis pathogenesis. We compared 15 osteoporotic and 14 healthy control MSC samples. We then analyzed the genetic signature in Ingenuity Pathway Analysis.Results.: The top canonical pathways identified that were statistically significant included the serine peptidase inhibitor kazal type 1 pancreatic cancer pathway, calcium signaling, pancreatic adenocarcinoma signaling, axonal guidance signaling, and glutamate receptor signaling. Upstream regulators involved in this disease process includedESR1, dexamethasone,CTNNβ1, CREB1, andERBB2.Conclusion.: Although there has been extensive research looking at the genetic basis for inflammatory arthritis, very little literature currently exists that has identified genetic pathways contributing to osteoporosis. Our study has identified several important genes involved in osteoporosis pathogenesis includingESR1, CTNNβ1, CREB1, andERBB2. ESR1has been shown to have numerous polymorphisms, which may play a prominent role in osteoporosis. The Wnt pathway, which includes theCTNNβ1gene identified in our study, plays a prominent role in bone mass regulation. Wnt pathway polymorphisms can increase susceptibility to osteoporosis. Our analysis also suggests a potential mechanism forERBB2in osteoporosis through Semaphorin 4D (SEMA4D). Our metaanalysis identifies several genes and pathways that can be targeted to develop new anabolic drugs for osteoporosis treatment.

1 January 2021 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
MRMichael Rohr
Michael Rohr
JAJihad Aljabban
Jihad Aljabban
TRTrina Rudeski-Rohr
Trina Rudeski-Rohr
SLSpencer Lessans
Spencer Lessans
SNSai Preethi Nakkina
Sai Preethi Nakkina
DADeborah Anne Altomare
Deborah Anne Altomare
INTRODUCTION: Bile acids (BAs) arising from duodenogastric reflux are known to facilitate gastric cancer (GC) development. Although BAs traditionally contribute to carcinogenesis through direct cellular cytotoxicity, increasing evidence implicates nuclear and membrane BA receptors (BARs) as additional factors influencing cancer risk. Indeed, some BARs are already linked with GC, but conflicting evidence and lack of information regarding other endogenous BARs warrant further investigation. In this study, we meta-analyzed multiple data sets to identify clinically relevant relationships between BAR expression and prognosis, clinicopathology, and activity in GC. METHODS: We collected transcriptomic data from the Gene Expression Omnibus and The Cancer Genome Atlas to analyze associations between BAR expression and GC prognosis, subtype, and clinicopathology. We also used Ingenuity Pathway Analysis to assess and predict functions, upstream regulators, and downstream mediators of membrane and nuclear BARs in GC. RESULTS: BARs showed differential distribution in GC; membrane BARs (G protein-coupled BAR 1, sphingosine-1-phosphate receptor 2, and cholinergic receptor muscarinic 2) were enriched in diffuse-, genome-stable, and mesenchymal-type tumors, whereas nuclear BARs (pregnane-X-receptor, constitutive androstane receptor, and farnesoid-X-receptor) were enriched in chromosome instability and metabolic subtypes. High expression of all membrane but not nuclear BARs was associated with poor prognosis and unfavorable GC clinicopathologic features. Similarly, expression patterns of membrane but not nuclear BARs varied geographically, aligning with Helicobacter pylori infection and GC mortality rates. Finally, GC-related oncogenes, namely transforming growth factor β1, were associated with membrane BARs, whereas many metabolic-associated genes were associated with nuclear BARs. DISCUSSION: Through transcriptomic meta-analysis, we identified distinct expression profiles between nuclear and membrane BARs that demonstrate prognostic relevance and warrant further investigation.

28 June 2023 in Heliyon
Verified
Journal Article
Open access
JAJihad Aljabban
Jihad Aljabban
SSSharjeel Syed
Sharjeel Syed
SSSaad Syed
Saad Syed
MRMichael Rohr
Michael Rohr
MMMohamed Mukhtar
Mohamed Mukhtar
DBDon Benson
Don Benson
The etiology of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) is still obscure as are the processes that enable the progression of MGUS to MM. Understanding the unique vs. shared transcriptomes can potentially elucidate why individuals develop one or the other. Furthermore, highlighting key pathways and genes involved in the pathogenesis of MM or the development of MGUS to MM may allow the discovery of novel drug targets and therapies.

14 October 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DADavid Zachariah Allen
David Zachariah Allen
JAJihad Aljabban
Jihad Aljabban
DSDustin Silverman
Dustin Silverman
SMSean McDermott
Sean McDermott
RWRoss A. Wanner
Ross A. Wanner
MPMaryam Panahiazar
Maryam Panahiazar
Background: Nasopharyngeal carcinoma (NPC) is a cancer of epithelial origin with a high incidence in certain populations. While NPC has a high remission rate with concomitant chemoradiation, recurrences are frequent, and the downstream morbidity of treatment is significant. Thus, it is imperative to find alternative therapies. Methods: We employed a Search Tag Analyze Resource (STARGEO) platform to conduct a meta-analysis using the National Center for Biotechnology’s (NCBI) Gene Expression Omnibus (GEO) to define NPC pathogenesis. We identified 111 tumor samples and 43 healthy nasopharyngeal epithelium samples from NPC public patient data. We analyzed associated signatures in Ingenuity Pathway Analysis (IPA), restricting genes that showed statistical significance (p<0.05) and an absolute experimental log ratio greater than 0.15 between disease and control samples. Results: Our meta-analysis identified activation of lipopolysaccharide (LPS)-induced tissue injury in NPC tissue. Additionally, interleukin-1 (IL-1) and SB203580 were the top upstream regulators. Tumorigenesis-related genes such as homeobox A10 (HOXA10) and prostaglandin-endoperoxide synthase 2 (PTGS2 or COX-2) as well as those associated with extracellular matrix degradation, such as matrix metalloproteinases 1 and 3 (MMP-1, MMP-3) were also upregulated. Decreased expression of genes that encode proteins associated with maintaining healthy nasal respiratory epithelium structural integrity, including sentan-cilia apical structure protein (SNTN) and lactotransferrin (LTF) was documented. Importantly, we found that etanercept inhibits targets upregulated in NPC and LPS induction, such as MMP-1, PTGS2, and possibly MMP-3. Conclusions: Our analysis illustrates that nasal epithelial barrier dysregulation and maladaptive immune responses are key components of NPC pathogenesis along with LPS-induced tissue damage.

17 January 2020 in Hepatology Forum
Verified
Journal Article
Open access
JAJihad Aljabban
Jihad Aljabban
NDNilay Danis
Nilay Danis
MGMerve Gurakar
Merve Gurakar
KKKamal Khorfan
Kamal Khorfan
NANabeal Aljabban
Nabeal Aljabban
BSBehnam Saberi
Behnam Saberi
Background and Aim: Hepatitis C is a leading cause of chronic liver disease and hepatocellular carcinoma (HCC). Understanding the evolution and biology of HCC among HCV patients may lead to novel therapeutic avenues and risk stratification. Material and Methods: Using meta-analysis platform STARGEO, we performed two separate meta-analyses as follows: 357 HCV-related HCC tumor samples with 220 adjacent non-tumor samples and 92 HCV-related cirrhotic liver samples with 53 healthy liver samples as a control. Then, we analyzed the signature in Ingenuity Pathway Analysis. Results: HCV cirrhosis analysis demonstrated LPS/IL-1 mediated inhibition of RXR function, LXR/RXR activation, sirtuin signaling, IL-10 signaling and hepatic fibrosis/stellate cell activation as top canonical pathways. IL1β, TNF, and TGF-β1 were top upstream regulators. Cellular morphologic and signaling changes were noted through the up-regulation of RGS1/2, WNT receptor FZD7, the TGF-β1-induced gap junction gene GJA1, and the zinc finger transcription factor repressor SNAI2. Apoptosis was inhibited through the down-regulation of OMA1. Metabolic dysfunction was noted through the down-regulation of SCLY and CBS. HCV-related HCC analysis showed FXR/RXR and LXR/RXR signaling, LPS/IL1-mediated inhibition of RXR activation, and melatonin degradation as top canonical pathways. Conclusion: Our results suggest that the genetic changes in the setting of chronic HCV infection predispose patients to developing HCC.

23 October 2018 in Informatics
Verified
Journal Article
Open access
PDF file
MPMaryam Panahiazar
Maryam Panahiazar
DFDarya Fadavi
Darya Fadavi
JAJihad Aljabban
Jihad Aljabban
LSLaraib Safeer
Laraib Safeer
IAImad Aljabban
Imad Aljabban
DHDexter Hadley
Dexter Hadley
A crucial factor in Big Data is to take advantage of available data and use that for new discovery or hypothesis generation. In this study, we analyzed Large-scale data from the literature to OMICS, such as the genome, proteome or metabolome, respectively, for skin conditions. Skin acts as a natural barrier to the world around us and protects our body from different conditions, viruses, and bacteria, and plays a big part in appearance. We have included Hyperpigmentation, Postinflammatory Hyperpigmentation, Melasma, Rosacea, Actinic keratosis, and Pigmentation in this study. These conditions have been selected based on reasoning of big scale UCSF patient data of 527,273 females from 2011 to 2017, and related publications from 2000 to 2017 regarding skin conditions. The selected conditions have been confirmed with experts in the field from different research centers and hospitals. We proposed a novel framework for large-scale available public data to find the common genotypes and phenotypes of different skin conditions. The outcome of this study based on Advance Data Analytics provides information on skin conditions and their treatments to the research community and introduces new hypotheses for possible genotype and phenotype targets. The novelty of this work is a meta-analysis of different features on different skin conditions. Instead of looking at individual conditions with one or two features, which is how most of the previous works are conducted, we looked at several conditions with different features to find the common factors between them. Our hypothesis is that by finding the overlap in genotype and phenotype between different skin conditions, we can suggest using a drug that is recommended in one condition, for treatment in the other condition which has similar genes or other common phenotypes. We identified common genes between these skin conditions and were able to find common areas for targeting between conditions, such as common drugs. Our work has implications for discovery and new hypotheses to improve health quality, and is geared towards making Big Data useful.